BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2966770)

  • 21. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
    Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive and hypotensive effects of atrial natriuretic factor in men.
    Weder AB; Sekkarie MA; Takiyyuddin M; Schork NJ; Julius S
    Hypertension; 1987 Dec; 10(6):582-9. PubMed ID: 2961688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of dopamine infusion on the release of atrial natriuretic factor].
    Fontana F; Ruffini M; Capelli M; Bernardi P
    G Ital Cardiol; 1990 Mar; 20(3):227-35. PubMed ID: 2140554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.
    Gaillard CA; Koomans HA; Rabelink TJ; Braam B; Boer P; Dorhout Mees EJ
    Hypertension; 1988 Oct; 12(4):450-6. PubMed ID: 2971618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
    Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
    Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose atrial natriuretic factor in primary aldosteronism: renal, hemodynamic, and vascular effects.
    Pedrinelli R; Panarace G; Spessot M; Taddei S; Favilla S; Graziadei L; Lucarini A; Salvetti A
    Hypertension; 1989 Aug; 14(2):156-63. PubMed ID: 2527199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that atrial natriuretic factor is the humoral factor by which volume loading or mannitol infusion produces an improved renal function after acute ischemia. An experimental study in dogs.
    Gianello P; Squifflet JP; Carlier M; Jamart J; Pirson Y; Mahy B; Berbinschi A; Donckier J; Ketelslegers JM; Lambotte L
    Transplantation; 1989 Jul; 48(1):9-14. PubMed ID: 2526402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atrial natriuretic peptide (99-126) in chronic renal disease in man.
    Swainson CP; Craig KC
    Nephrol Dial Transplant; 1991; 6(5):336-41. PubMed ID: 1831249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin attenuates the natriuretic response to atrial natriuretic factor in man.
    Lang CC; Choy AM; Balfour DJ; Struthers AD
    Kidney Int; 1992 Aug; 42(2):433-41. PubMed ID: 1405327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypotensive and diuretic effects of atrial natriuretic factor in diabetic patients.
    Pusterla C; Beretta-Piccoli C; Weidmann P; Nessi M; Shaw S
    J Hum Hypertens; 1989 Apr; 3(2):79-87. PubMed ID: 2527302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal-endocrine adaptations to endogenous atrial natriuretic factor during tachycardia-induced reductions in renal perfusion pressure.
    Miller WL; Edwards BS; Zimmerman RS; Burnett JC
    Circ Res; 1990 Jan; 66(1):76-83. PubMed ID: 2136813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F; Guardigli G; Cappelli M; Bernardi P
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of renal actions of urodilatin and atrial natriuretic peptide.
    Hildebrandt DA; Mizelle HL; Brands MW; Hall JE
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure.
    Selçuk Y; San A; Bakan E; Yiğitoğlu R
    Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natriuretic and diuretic effects of infusion of atrial natriuretic factor in conscious dogs.
    Ohanian J; Young MA; Shen YT; Gaivin R; Vatner SF; Graham RM
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F565-73. PubMed ID: 2529778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.
    Meyer-Lehnert H; Bayer T; Predel HG; Glänzer K; Kramer HJ
    Klin Wochenschr; 1991 Nov; 69(19):895-903. PubMed ID: 1667425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.
    Adnot S; Andrivet P; Chabrier PE; Piquet J; Plas P; Braquet P; Roudot-Thoraval F; Brun-Buisson C
    J Clin Invest; 1989 Mar; 83(3):986-93. PubMed ID: 2522105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes.
    Miller JA; Floras JS; Zinman B; Skorecki KL; Logan AG
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R442-50. PubMed ID: 8141401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial natriuretic factor after dopamine infusion in healthy subjects and in congestive heart failure.
    Fontana F; Bernardi P; Ruffini M; Capelli M
    Eur Heart J; 1991 Jul; 12(7):803-6. PubMed ID: 1832381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR; Thibault G; Kuchel O; Hamet P; Cantin M; Larochelle P
    J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.